Bryostatin-1 Restores Hippocampal Synapses and Spatial Learning and Memory in Adult Fragile X Mice

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of Pharmacology and Experimental Therapeutics

• Publication date

  2014-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1124/jpet.114.214098PMID 24659806
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• CNS expression of murine fragile X protein (FMRP) as a function of CGG-repeat size.

  2014cited by this paper
• Portraying inhibition of metabotropic glutamate receptor 5 in fragile X mice.

  2014cited by this paper
• The Developmental Switch in GABA Polarity Is Delayed in Fragile X Mice

  2014cited by this paper
• Phenotypes of hypofrontality in older female fragile X premutation carriers

  2013cited by this paper
• Circuit level defects in the developing neocortex of fragile X mice

  2013cited by this paper
• Homeostatic Responses Fail to Correct Defective Amygdala Inhibitory Circuit Maturation in Fragile X Syndrome

  2013cited by this paper
• The translation of translational control by FMRP: therapeutic targets for FXS

  2013cited by this paper
• Loss of Functional A-Type Potassium Channels in the Dendrites of CA1 Pyramidal Neurons from a Mouse Model of Fragile X Syndrome

  2013cited by this paper
• Altered Structural and Functional Synaptic Plasticity with Motor Skill Learning in a Mouse Model of Fragile X Syndrome

  2013cited by this paper
• The effect of an mGluR5 inhibitor on procedural memory and avoidance discrimination impairments in Fmr1 KO mice

  2012cited by this paper
• Molecular mechanisms of fragile X syndrome: a twenty-year perspective.

  2012cited by this paper
• Evidence for a Fragile X Mental Retardation Protein-Mediated Translational Switch in Metabotropic Glutamate Receptor-Triggered Arc Translation and Long-Term Depression

  2012cited by this paper
• Designed, Synthetically Accessible Bryostatin Analogues Potently Induce Activation of Latent HIV Reservoirs in vitro

  2012influential reference
• Fragile X syndrome therapeutics S(C)TEP through the developmental window.

  2012cited by this paper
• Inhibition of GSK3β improves hippocampus-dependent learning and rescues neurogenesis in a mouse model of fragile X syndrome.

  2012cited by this paper
• Pharmacological treatment of fragile X syndrome with GABAergic drugs in a knockout mouse model.

  2012cited by this paper
• Activation of the extracellular signal‐regulated kinase pathway contributes to the behavioral deficit of fragile x‐syndrome

  2012cited by this paper
• Organic Synthesis Toward Small-Molecule Probes and Drugs Special Feature: Design, synthesis, and evaluation of potent bryostatin analogs that modulate PKC translocation selectivity

  2011cited by this paper
• Reversal of Fragile X Phenotypes by Manipulation of AβPP/Aβ Levels in Fmr1KO Mice

  2011cited by this paper
• Fragile X mental retardation protein regulates heterosynaptic plasticity in the hippocampus.

  2011cited by this paper
• Fragile X Mental Retardation Protein Regulates New Neuron Differentiation in the Adult Olfactory Bulb

  2011cited by this paper
• PKC ε Activation Prevents Synaptic Loss, Aβ Elevation, and Cognitive Deficits in Alzheimer's Disease Transgenic Mice

  2011cited by this paper
• Fragile X Syndrome: The GABAergic System and Circuit Dysfunction

  2011cited by this paper
• Fragile X mental retardation protein is required for synapse elimination by the activity-dependent transcription factor MEF2.

  2010cited by this paper
• Profiling Fragile X Syndrome in males: strengths and weaknesses in cognitive abilities.

  2010cited by this paper
• Delayed Stabilization of Dendritic Spines in Fragile X Mice

  2010influential reference
• Defective GABAergic Neurotransmission and Pharmacological Rescue of Neuronal Hyperexcitability in the Amygdala in a Mouse Model of Fragile X Syndrome

  2010cited by this paper
• Critical period plasticity is disrupted in the barrel cortex of FMR1 knockout mice.

  2010cited by this paper
• Lithium ameliorates altered glycogen synthase kinase-3 and behavior in a mouse model of fragile X syndrome.

  2010cited by this paper
• Group 1 mGluR-dependent synaptic long-term depression: mechanisms and implications for circuitry and disease.

  2010cited by this paper
• Fragile X syndrome and model organisms: identifying potential routes of therapeutic intervention

  2010cited by this paper
• Elevated glycogen synthase kinase-3 activity in Fragile X mice: key metabolic regulator with evidence for treatment potential.

  2009cited by this paper
• Reduction of β-Amyloid Levels by Novel Protein Kinase Cϵ Activators

  2009cited by this paper
• REDUCTION OF BETA-AMYLOID LEVELS BY NOVEL PKC EPSILON ACTIVATORS

  2009cited by this paper
• Poststroke neuronal rescue and synaptogenesis mediated in vivo by protein kinase C in adult brains

  2008cited by this paper
• Insulin, PKC signaling pathways and synaptic remodeling during memory storage and neuronal repair.

  2008influential reference
• Brain-Derived Neurotrophic Factor Rescues Synaptic Plasticity in a Mouse Model of Fragile X Syndrome

  2007cited by this paper
• The GABAA receptor: a novel target for treatment of fragile X?

  2007cited by this paper
• A structural basis for enhancement of long-term associative memory in single dendritic spines regulated by PKC

  2007influential reference
• PKC signaling deficits: a mechanistic hypothesis for the origins of Alzheimer's disease.

  2007influential reference
• A new function for the fragile X mental retardation protein in regulation of PSD-95 mRNA stability

  2007cited by this paper
• Decreased expression of the GABAA receptor in fragile X syndrome.

  2006cited by this paper
• Local Protein Synthesis and Spine Morphogenesis: Fragile X Syndrome and Beyond

  2006cited by this paper
• Protein synthesis required for long-term memory is induced by PKC activation on days before associative learning.

  2005cited by this paper
• Deletion of FMR1 in Purkinje cells enhances parallel fiber LTD, enlarges spines, and attenuates cerebellar eyelid conditioning in Fragile X syndrome.

  2005cited by this paper
• Dual effects of bryostatin-1 on spatial memory and depression.

  2005cited by this paper
• Dendritic spines disappear with chilling but proliferate excessively upon rewarming of mature hippocampus.

  2004cited by this paper
• The RNA binding protein FMRP: new connections and missing links

  2003cited by this paper
• Autistic-like behaviour profile and psychiatric morbidity in Fragile X Syndrome

  2003cited by this paper
• Autistic-like behaviour profile and psychiatric morbidity in Fragile X Syndrome

  2003cited by this paper
• Overview on the structure, composition, function, development, and plasticity of hippocampal dendritic spines

  2000cited by this paper
• Genotype, molecular phenotype, and cognitive phenotype: correlations in fragile X syndrome.

  1999cited by this paper
• Role of protein kinase C phosphorylation in rapid desensitization of metabotropic glutamate receptor 5.

  1998cited by this paper
• Fragile X mental retardation protein is translated near synapses in response to neurotransmitter activation.

  1997cited by this paper
• Fragile X syndrome

  1996cited by this paper
• Differential regulation of protein kinase C isozymes by bryostatin 1 and phorbol 12-myristate 13-acetate in NIH 3T3 fibroblasts.

  1994influential reference
• A simulation of action potentials in synaptic boutons during presynaptic inhibition.

  1994cited by this paper
• FMR1 protein: conserved RNP family domains and selective RNA binding.

  1993cited by this paper
• Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome.

  1991cited by this paper
• Fragile X mental retardation.

  1989cited by this paper
• Modeling of the bryostatins to the phorbol ester pharmacophore on protein kinase C.

  1988cited by this paper
• Proc. Nat. Acad. Sei

  1978cited by this paper

• Targeted Discovery of β-Branched Conjugated Polyketides from Bacteria Based on Genomic and Metabolomic Hallmarks

  2026cites this paper
• Protein Kinase C Family: Structures, Biological Functions, Diseases, and Pharmaceutical Interventions

  2025cites this paper
• Bryostatins 1 and 3 inhibit TRPM8 and modify TRPM8- and TRPV1-mediated lung epithelial cell responses to a proinflammatory stimulus via protein kinase C

  2025cites this paper
• Bryostatin-1 improves function in arteries with suppressed endothelial cell autophagy.

  2025cites this paper
• Unveiling promising drug targets for autism spectrum disorder: insights from genetics, transcriptomics, and proteomics

  2024cites this paper
• Bryostatin-1 protects against amyloid- beta (Aβ) oligomer-induced neurotoxicity by activating autophagy

  2024cites this paper
• Bryostatin-1: a promising compound for neurological disorders

  2023influential citation
• Dual Regulation of Spine-Specific and Synapse-to-Nucleus Signaling by PKCδ during Plasticity

  2023cites this paper
• Mouse models of fragile X-related disorders

  2023cites this paper
• Practical synthesis of the therapeutic leads tigilanol tiglate and its analogues.

  2022cites this paper
• Unlocking the Drug Potential of the Bryostatin Family: Recent Advances in Product Synthesis and Biomedical Applications.

  2020cites this paper
• Function-Oriented Synthesis: Design, Synthesis, and Evaluation of Highly Simplified Bryostatin Analogues.

  2020cites this paper
• APOE4 genetic polymorphism results in impaired recovery in a repeated mild traumatic brain injury model and treatment with Bryostatin-1 improves outcomes

  2020cites this paper
• L-3-n-Butylphthalide improves synaptic and dendritic spine plasticity and ameliorates neurite pathology in Alzheimer’s disease mouse model and cultured hippocampal neurons

  2020cites this paper
• Chronic bryostatin-1 rescues autistic and cognitive phenotypes in the fragile X mice

  2020cites this paper
• A multitude of signaling pathways associated with Alzheimer's disease and their roles in AD pathogenesis and therapy

  2020cites this paper
• Bryostatin 1 Promotes Synaptogenesis and Reduces Dendritic Spine Density in Cortical Cultures through a PKC-Dependent Mechanism.

  2020cites this paper
• Prodrugs of PKC modulators show enhanced HIV latency reversal and an expanded therapeutic window

  2020cites this paper
• Synthesis and evaluation of designed PKC modulators for enhanced cancer immunotherapy

  2020cites this paper
• Preclinical and clinical studies on bryostatins, a class of marine-derived protein kinase C modulators: A mini-review.

  2020cites this paper
• Munc13 Is a Molecular Target of Bryostatin 1

  2019cites this paper
• Potential Enzymatic Targets in Alzheimer's: A Comprehensive Review.

  2019cites this paper
• Of Men and Mice: Modeling the Fragile X Syndrome

  2018cites this paper
• Neonatal Stimulation of PKC Epsilon Signaling Normalizes Fragile X-Associated Deficits in PVN Oxytocin Expression and Later-Life Social and Anxiety Behavior

  2018cites this paper
• Bryostatin-1 alleviates experimental multiple sclerosis

  2018cites this paper
• Review of Salient Investigational Drugs for the Treatment of Fragile X Syndrome

  2017cites this paper
• Interference of the complex between NCS-1 and Ric8a with phenothiazines regulates synaptic function and is an approach for fragile X syndrome

  2017cites this paper
• Drugs in Clinical Trials for Alzheimer's Disease: The Major Trends

  2017cites this paper
• Endothelial Cell Autophagy Maintains Shear Stress–Induced Nitric Oxide Generation via Glycolysis-Dependent Purinergic Signaling to Endothelial Nitric Oxide Synthase

  2017cites this paper
• Platycodon grandiflorus Root Extract Improves Learning and Memory by Enhancing Synaptogenesis in Mice Hippocampus

  2017cites this paper
• Neurotrophic Factors in Mouse Models of Autism Spectrum Disorder: Focus on BDNF and IGF-1.

  2017cites this paper
• Bryostatin Effects on Cognitive Function and PKCɛ in Alzheimer’s Disease Phase IIa and Expanded Access Trials

  2017cites this paper
• Molecular dynamics simulations reveal ligand-controlled positioning of a peripheral protein complex in membranes

  2017cites this paper
• Rescue of Synaptic Phenotypes and Spatial Memory in Young Fragile X Mice

  2016influential citation
• Astrocyte-secreted thrombospondin-1 modulates synapse and spine defects in the fragile X mouse model

  2016cites this paper
• Elucidating and Pharmacologically Targeting Secondary Injury Cascades following Neural Injury

  2016cites this paper
• Running title : Rescuing synapses and spatial memory in young fragile X mice

  2016cites this paper
• Protein Kinase Cϵ (PKCϵ) Promotes Synaptogenesis through Membrane Accumulation of the Postsynaptic Density Protein PSD-95*

  2016cites this paper
• [A review of drugs for treatment of Alzheimer's disease in clinical trials: main trends].

  2016cites this paper
• PKC epsilon Promotes Synaptogenesis through Membrane Accumulation of the Postsynaptic Density Protein PSD-95

  2016cites this paper
• Effect of Boric Acid Supplementation on the Expression of BDNF in African Ostrich Chick Brain

  2015cites this paper
• Towards universal therapeutics for memory disorders.

  2015cites this paper
• Bioactive Compounds from Marine Extremophiles

  2015cites this paper
• Learning and behavioral deficits associated with the absence of the fragile X mental retardation protein: what a fly and mouse model can teach us

  2014cites this paper
• Rescue of fragile X syndrome phenotypes in Fmr1 KO mice by a BKCa channel opener molecule

  2014cites this paper
• Bryostatin-1 Restores Blood Brain Barrier Integrity following Blast-Induced Traumatic Brain Injury

  2014cites this paper